Epidémiologie des Maladies Emergentes : Projets
|
HCV research in Egypt
(Institut Pasteur, INSERM, French Hospitals, University of Cairo, University of Ain Shams, Minia University, Mansoura University; Coordination: Arnaud Fontanet & Gamal Esmat). |
The main research objectives of this multidisciplinary network funded by the ANRS and the EC are the assessment of the burden of HCV infection and disease in Egypt, the study of factors associated with HCV transmission for designing better prevention programs, the optimization of drug regimens for the treatment of acute and chronic hepatitis C, and the study of factors associated with spontaneous HCV clearance in acute hepatitis C for vaccine development. The project has been successful in attracting twenty international research grants (from the EC, ANRS, and Wellcome Trust), and has already led to more than 25 publications in international peer-reviewed journals. The ANRS network has been very involved in the elaboration of the 2013-2018 Egypt National Strategy for the Control of Viral Hepatitis through the National Committee against Viral Hepatitis (headed by Gamal Esmat) and the WHO Technical Advisory Group to the Ministry of Health (chaired by Arnaud Fontanet). A more detailed description of the research objectives and findings is available on the project’s website: http://www.hepnile.org/
Publications
Grants
Description détaillée du programme de recherche
Stratégie nationale de lutte contre les hépatites virales en Egypte
|
Ac Mong Virus Encephalitis (AVE) Project: Investigation of unexplained acute encephalitis outbreaks in Northern Vietnam
(Collaborators: Phan Thi Nga, Hanoi; Paul Brey, IP Vientiane; Jean-Claude Manuguerra, Antoine Gessain, Marc Eloit, Matthew Albert, Olivier Lortholary, Juliette Paireau, Arnaud Fontanet, IP Paris). |
More than 50% of acute encephalitis cases have no etiologic agent in the industrialized world (Huppatz C. et al., Emerg Infect Dis, 2009). The advent of new high-throughput sequencing techniques and of microarrays that permit the detection of hundreds of viral sequences from a range of viruses may help us to attribute several of these unexplained acute encephalitis to an etiologic agent. In the hope of identifying a new viral agent, we recently formed a collaborative group of epidemiologists, virologists, clinicians, immunologists, and entomologists to investigate outbreaks of pediatric acute encephalitis occurring in Northern Vietnam during the litchi harvests (months of June-July) since the end of the 1990s (AVE project, ANR MIEN-003-2008; Scientific Coordinator: Arnaud Fontanet). Epidemiological investigations performed by our group with colleagues from the National Institute of Hygiene and Epidemiology (NIHE, Hanoi) have confirmed the ecologic association between the occurrence of acute encephalitis cases and the proportion of litchi surface plantations at the commune level (n=230 communes) (Paireau et al, Emerg Infect Dis, 2012).
This analysis was initiated to examine the local belief that these outbreaks started after the recent intensification of litchi production in the region, and after similar unexplained outbreaks of acute encephalitis took place around litchi plantations of the Bihar State in India. The link between the litchi trees and the emergence of this new disease remains unexplained. The clinical, biological and immunologic characteristics of patients suggest a viral etiology. No new virus has yet been identified but viral investigations on patients’ serum and cerebrospinal fluid are in progress. This project has been integrated in the general section on emerging pathogens of the recently awarded Labex IBEID (Integrative Biology of Emerging Infectious Diseases), coordinated by Pascale Cossart and Philippe Sansonnetti.
|
Acute Bacterial Meningitis Project: Investigation of the spatio-temporal dynamics of meningitis epidemics in Niger and the associated ecologic risk factors
(Collaborators: Halima B. Mainassara, Jean-Paul Moulia-Pelat, Jean-François Jusot, Odile Ouwe Missi Oukem, CERMES, Niamey; Juliette Paireau, Judith Mueller, Arnaud Fontanet, IP Paris). |
Funding : DCI Monaco.
In collaboration with epidemiologists from the Centre de Recherche Médicale et Sanitaire (CERMES) in Niamey, we are using recent advances in Geographic Information Systems and statistical methodology to investigate the spatio-temporal dynamics of meningitis epidemics in Niger at a fine geographic scale (health centres) and the associated risk factors (project funded by the Office of International Cooperation of the Principality of Monaco ; Scientific Coordinator: Arnaud Fontanet).
Spatial analyses first revealed the highly localized nature of these annual epidemics, constituted by small spatial clusters of cases (Paireau et al, PLoS Negl Trop Dis, 2012). We identified heterogeneous spatio-temporal patterns, with emergence of outbreaks in different areas from year to year, followed by spread in variable geographic directions. We also showed that surveillance at a fine spatial scale would be more efficient for public health response: outbreaks would be detected earlier and reactive vaccination would be better targeted. The factors that could explain the observed spatio-temporal patterns at the health centre scale are still poorly understood and statistical models are under development in our group, integrating jointly climatic, environmental, socio-demographic and vaccination data.
Our findings should help to improve control of meningitis in sub-Saharan Africa, especially in the context of introduction of a new meningococcal A conjugate vaccine.
|
Epidemiology of Buruli ulcer in Cameroon
(Collaborators: Laurent Marsollier, Angers University; Jean-François Guégan, IRD; Sara Eyangoh, CPC Yaoundé; Jordi Landier, Arnaud Fontanet, IP Paris). |
Funding: ANR, Fondation Raoul Follereau, Fondation SANOFI Espoir.
In this new research program, we will conduct for the first time the simultaneous collection of environmental (plants and insects) and human samples in two historically endemic regions located in different climates (equatorial and subtropical in Cameroon and Benin, respectively) and one newly discovered endemic focus close to a dam (in Cameroon). Samples will be analysed for the presence of M.ulcerans, and characterised phylogenetically, to offer better understanding of the circulation of M.ulcerans across ecological niches. Maps of M. ulcerans presence probability, as well as of M. ulcerans exposure risk, will be produced at the regional scale and tentatively expanded at the national scale, to target more efficiently diagnostic and care resources.
We will also focus on the role of peri-domestic insects in M.ulcerans transmission. Indeed, two studies of our group suggest that individuals sleeping under mosquito nets are at a lower risk of Buruli ulcer than those who do not. Knowing that in Australia, mosquitoes are considered as potential vectors for M.ulcerans (Lavender C.J. et al., PLoS NTD, 2011), and repellents are recommended for protection against Buruli ulcer, we seek to expand our initial studies by capturing insects around houses and using PCR to search for M.ulcerans DNA in these insects.
|
TORCADIA : Epidemiology of severe childhood diarrhea: A case control study in the Central African Republic (CAR)
(Collaborators: Sébastien Breurec, Ionela Gouandjika,Thierry Frank, Caroline Martin (IP Bangui), Petulla bata, Jean Gody (Complexe pédiatrique Bangui), Tamara Giles-Vernick, Loic chartier, Muriel Vray (IP Paris)). |
Funding : The fondation Total.
Diarrhea ranks as the world’s third most deadly infection in children, claiming some 2.2 million lives each year, of whom two million are under five years old. In the absence of laboratory tests, the presumptive treatment leads to an overestimation of possible bacterial diarrheas and of the overuse of antibiotic treatments, which can lead to the emergence of antibiotic resistant strains. In CAR, childhood diarrhea constitutes one of the most important public health problems, with a global prevalence estimated at 19%, and reaching 30% among children between 12 and 23 months old.
This study, which will include 600 HIV-negative children, hospitalized for severe diarrhea and a control group of 600 children, matched by sex, age, and neighborhood of residence, has the following primary objectives:
1) Identify the pathogens implicated in diarrhea;
2) Measure antibiotic resistance of different isolated bacterial strains;
3) Study over the short term the characteristics, evolution and sequellae of severe diarrhea;
4) Identify the risk factors (socio-economic, alimentary, environmental) associated with severe diarrhea;
5) Evaluate using an anthropological approach the practices and local concepts surrounding childhood diarrhea, as well as the treatment and feeding of diarrheal children.
All cases will undergo clinical examination, consisting of anthropometric measures, parasitological, virological, and bacteriological analyses of stool samples, and blood testing. For the controls, anthropometric measurements and a stool exam will be carried out.
Expected results:
This study will reinforce the knowledge of the epidemiology and etiologies of severe childhood diarrhea. In addition, it will also improve knowledge of the characteristics, evolution and sequellae of diarrhea that necessitate hospitalization. The analysis of antibiotic resistance of isolated strains and genotypical and phenotypical factors of virulence will help to strengthen algorithms for the care management of patients. The anthropological approach, which seeks to identify the understandings and practices of mothers confronted with diarrheal children, should also assist in improving the management of children’s care.
|
MACOMBA : Pragmatic clinical trial comparing a prophylactic treatment of cotrimoxazole (CTX) with sulfadoxine-pyriméthamine (SP) for malaria among pregnant women infected with HIV in Bangui. |
Accounting for HIV serological status in patients is critically important for effective malaria prevention. CTX is recommended for preventing opportunistic infections in HIV positive women with CD4 count < 350 clls/mm3. The efficacy of CTX as a prophylaxis for P. falciparum malaria is well known. A clinical trial (CTX versus SP) undertaken among children in Bandiagara, Mali reported a protective efficacy of 99.7%. The WHO and the Central African Republic (CAR) recommend intermittent SP as malaria prophylaxis for pregnant women. Therefore it is superfluous and contraindicated to provide SP and CTX together in HIV-positive persons when CD4 is <350 cells/mm3. In contrast, few studies until now have described the efficacy of CTX in the prevention of malaria among pregnant women, and particularly its efficacy in an environment in which frequent therapeutic failures of SP are on the rise, as is the case in the CAR. Finally, although existing studies have not confirmed this hypothesis, there remain persistent concerns about the possible development of cross-resistance in P. falciparum to both CTX and SP because of their similar modes of action.
The principal objective of this randomized, open label trial, carried out under real-life conditions of care, is to demonstrate the superiority of CTX (administered as a daily dose until childbirth) over SP (administered as directly observed treatment of three doses) on placental malaria parasitaemia in HIV-positive pregnant women whose CD4 count > 350 cells/mm3. This study will also permit to compare the two treatments in terms of the incidence of malaria episodes during pregnancy, profiles of resistant parasites isolated during these malaria episodes and in the placenta during childbirth, material anemia, birth weight, and infant anemia. An evaluation of adherence to the CTX treatment will be conducted at each prenatal visit; women included in the trial will be asked to report the number of pills remaining in their possession. We plan to recruit 150 women in each group.
Expected results:
The principal hypothesis is that CTX is more efficacious than SP on placental malaria parasitaemia. This result could be explained by higher plasma levels among those taking CTX. The verification of this hypothesis will permit the recommendation of CTX as a prophylactic treatment for malaria among HIV-positive women, regardless of CD4 count.
|
Malaria in southwestern Burkina Faso
(Collaborators : Tamara Giles-Vernick, Abdoulaye Traoré, Sodiomon B. Sirima). |
The primary aim is to test the acceptability and feasibility of an intervention package for the community management of childhood malaria. The package includes rapid diagnostic testing, coartem and referral of serious cases to the nearest health care center; pre-treatment of serious cases is currently being analysed. Beginning in mid-2013, the community management strategy will be carried out by trained community health workers and medical personnel. For the qualitative part of this study, our primary interest is to investigate the changing ways that parents in southwestern Burkina Faso have understood the etiologies, treatment and control of local categories of illnesses that are related to “malaria” but not understood in precisely the same way. The aim of this research question is to tailor the use of the intervention package in such a way that it is meaningful to southwestern Burkinabe populations.
Publication
|
THE EMERGENCE OF HIV IN AFRICA : Ethnomedical and historical perspectives
(Collaborators : William S Schneider, Indiana University, Guillaume Lachenal, Université de Paris Diderot Sorbonne Paris Cité, Ch. Didier Gondola, Indiana University, Tamara Giles-Vernick, IP Paris). |
Publications
|
PROJETS RECEMMENT TERMINES |
Projet EPISARS : Prévention de la réémergence du SRAS (Coordinateur Scientifique : Arnaud Fontanet, IP, et HU Zhihong, Wuhan Institute, Chine)
Ce projet impliquant 10 équipes de recherche européennes, et 8 chinoises, a contribué à l’identification du réservoir animal du coronavirus du SRAS, la chauve-souris (Li et coll., Science, 2005), et à la confirmation du rôle joué par les civettes comme hôte intermédiaire responsable du passage du virus vers l’homme (Song et coll., PNAS, 2005). Le projet a fait l’objet de 35 publications dans des revues internationales à comité de lecture.
Pour plus d’infos
Publications
DENFRAME : ‘Innovative Diagnostic Tools and therapeutic approaches for dengue disease'. (Coordination: L Baril et P Despres)
Pour plus d’infos
Essai randomisé de traitement de l'hépatite chronique B au Sénégal (Coordination : M. Vray et P.S. Mbaye)
Publications
Modélisation de la transmission du VIH (Michel Garenne & Pauline Leclerc, IP, et Allan Matthews, Université du KwaZulu-Natal, Afrique du Sud)
Publications
Efficacité des vaccins du Programme Elargi de Vaccination chez les enfants infectés par le VIH (Laurence Baril, IP Paris, Mathurin Tejiokem, CPC Yaouné, I Gouandjika, IP de Bangui)
Publications
Diagnostic des infections opportunistes chez les patients infectés par le VIH et algorithmes de prise en charge dans les pays du Sud (M. Vray, Y. Madec et A. Fontanet, IP Paris, et IP de Dakar, Bangui, Phnom Penh et Ho Chi Minh)
Publications
Efficacité des traitements antirétroviraux des programmes de Médecins Sans Frontières (MSF) en Asie et en Afrique (Yoann Madec et Arnaud Fontanet, IP)
Publications